<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03814889</url>
  </required_header>
  <id_info>
    <org_study_id>49330</org_study_id>
    <nct_id>NCT03814889</nct_id>
  </id_info>
  <brief_title>Passive Tactile Stimulation for Stroke Rehabilitation</brief_title>
  <acronym>PTS</acronym>
  <official_title>Passive Tactile Stimulation for Stroke Rehabilitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stroke can lead to weakness and spasticity in the arm or hand. The purpose of this study is&#xD;
      to optimize the design of gentle vibratory stimulation delivered to the hands of individuals&#xD;
      with chronic stroke, and explore the effect on range of movement and spasticity.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 15, 2019</start_date>
  <completion_date type="Anticipated">April 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Modified Ashworth at 12 weeks</measure>
    <time_frame>Change from Baseline Modified Ashworth at 12 weeks</time_frame>
    <description>Modified Ashworth Scale for Spasticity (upper limb)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Modified Ashworth at 8 weeks</measure>
    <time_frame>Change from Baseline Modified Ashworth at 8 weeks</time_frame>
    <description>Modified Ashworth Scale for Spasticity (upper limb)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Range of Motion at 12 weeks</measure>
    <time_frame>Change from Baseline Range of Motion at 12 weeks</time_frame>
    <description>Workspace of voluntary movement of arm will be measured</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Range of Motion at 8 weeks</measure>
    <time_frame>Change from Baseline Range of Motion at 8 weeks</time_frame>
    <description>Workspace of voluntary movement of arm will be measured</description>
  </primary_outcome>
  <number_of_arms>11</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Stroke</condition>
  <condition>Stroke, Ischemic</condition>
  <condition>Stroke Hemorrhagic</condition>
  <condition>Spasticity as Sequela of Stroke</condition>
  <arm_group>
    <arm_group_label>Vibration pattern 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each tactile vibration pattern will consist of a specific vibration frequency, amplitude, and temporal sequence to be specified via pilot studies.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vibration pattern 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each tactile vibration pattern will consist of a specific vibration frequency, amplitude, and temporal sequence to be specified via pilot studies.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vibration pattern 3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each tactile vibration pattern will consist of a specific vibration frequency, amplitude, and temporal sequence to be specified via pilot studies.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vibration pattern 4</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each tactile vibration pattern will consist of a specific vibration frequency, amplitude, and temporal sequence to be specified via pilot studies.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vibration pattern 5</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each tactile vibration pattern will consist of a specific vibration frequency, amplitude, and temporal sequence to be specified via pilot studies.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vibration pattern 6</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each tactile vibration pattern will consist of a specific vibration frequency, amplitude, and temporal sequence to be specified via pilot studies.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vibration pattern 7</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each tactile vibration pattern will consist of a specific vibration frequency, amplitude, and temporal sequence to be specified via pilot studies.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vibration pattern 8</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each tactile vibration pattern will consist of a specific vibration frequency, amplitude, and temporal sequence to be specified via pilot studies.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vibration pattern 9</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each tactile vibration pattern will consist of a specific vibration frequency, amplitude, and temporal sequence to be specified via pilot studies.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vibration pattern 10</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Each tactile vibration pattern will consist of a specific vibration frequency, amplitude, and temporal sequence to be specified via pilot studies.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No vibration</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A light will blink instead of a vibration pattern being displayed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vibration pattern</intervention_name>
    <description>PHASE 1 and PHASE 2 are pilot studies not included in the clinical trial.&#xD;
Phase 2b: All participants try on several wearable prototypes in our laboratory that provide vibration to the arm. Sensors or electrodes taped onto the arm and hand will sense muscle activity and record any changes during periods of vibration and periods with vibration turned off.&#xD;
PHASE 3: Patients will be given a wearable device to take home. The patient will wear the device daily. At the beginning and end of the phase, arm function will be tested.&#xD;
PHASE 4: This study takes 3 or 6 months. 1) If the patient gets Botox injections in their hand and arm, their arm function will be measured for three months during this standard care. 2) Next, all patients will be given a wearable device to take home. The patient will wear the device while feeling vibrations for 3 hours during the day while awake for two months. During this time and 1 month after this intervention, arm function will be tested.</description>
    <arm_group_label>Vibration pattern 1</arm_group_label>
    <arm_group_label>Vibration pattern 10</arm_group_label>
    <arm_group_label>Vibration pattern 2</arm_group_label>
    <arm_group_label>Vibration pattern 3</arm_group_label>
    <arm_group_label>Vibration pattern 4</arm_group_label>
    <arm_group_label>Vibration pattern 5</arm_group_label>
    <arm_group_label>Vibration pattern 6</arm_group_label>
    <arm_group_label>Vibration pattern 7</arm_group_label>
    <arm_group_label>Vibration pattern 8</arm_group_label>
    <arm_group_label>Vibration pattern 9</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>No vibration</intervention_name>
    <description>These patients will wear a glove with a blinking light instead of feeling vibrations.</description>
    <arm_group_label>No vibration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 and older.&#xD;
&#xD;
          -  diagnosis of stroke with upper extremity spasticity or other movement deficits that&#xD;
             affect strength and range of movement.&#xD;
&#xD;
          -  willing to participate in the vibrotactile stimulation sessions for consecutive days&#xD;
             and willing to return for follow up visits as needed for the PHASE in progress.&#xD;
&#xD;
          -  able to provide informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with severe contracture that precludes Modified Ashworth Score (MAS) testing.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Allison M Okamura, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford Neuroscience Health Center</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>January 16, 2019</study_first_submitted>
  <study_first_submitted_qc>January 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 24, 2019</study_first_posted>
  <last_update_submitted>November 11, 2021</last_update_submitted>
  <last_update_submitted_qc>November 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Allison Okamura</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>spasticity</keyword>
  <keyword>tone</keyword>
  <keyword>hemiplegia</keyword>
  <keyword>hemiparesis</keyword>
  <keyword>arm</keyword>
  <keyword>hand</keyword>
  <keyword>vibration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Spasticity</mesh_term>
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Hemorrhagic Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

